Viewing Study NCT00611403


Ignite Creation Date: 2025-12-24 @ 7:41 PM
Ignite Modification Date: 2025-12-30 @ 8:36 PM
Study NCT ID: NCT00611403
Status: COMPLETED
Last Update Posted: 2011-12-20
First Post: 2008-01-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
Sponsor: Allergan
Organization:

Study Overview

Official Title: Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
Status: COMPLETED
Status Verified Date: 2011-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will evaluate the safety and efficacy of cyclosporine ophthalmic emulsion administered twice daily following LASIK surgery
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: